Researchers find a region of the brain stem called the periaqueductal gray may mediate religiosity and spirituality in humans.
A de novo mutation of SOS1, a gene implicated in Noonan syndrome, may be implicated in sudden infant death, researchers report.
Opioid use disorder affects genes associated with proinflammatory immune molecule encoding and genes associated with remodeling the extracellular matrix, suggesting the connection between neurons may be altered as a result of opioid use. Additionally, those with OUD have higher levels of microglia in the brain.
The recently discovered Homo longi lineage may be our closest relative. The findings have the potential to reshape our understanding of human evolution.
Taking SSRI antidepressants does not increase the risk of developmental delays or autism in children, a new study reports. However, there is an increased risk for ASD and developmental delays in children whose mothers suffer from maternal psychiatric disorders.
A twenty-year study has identified an association between childhood depression and an increased risk of physical and mental health problems as adults. Researchers found those with childhood depression had a greater risk of anxiety, substance use disorders, physical health problems, and an increased risk of engaging in criminal activity as adults.
Functional connectivity was reduced within and between several brain networks in children raised in disadvantaged neighborhoods. Researchers say a positive home and school environment can mitigate some of the effects.
Peripheral and brain markers for fear differ in a hormone dependent manner between males and females.
Researchers have identified novel neurocircuitry between midbrain structures which are modulated by leptin to control eating behaviors in mice.
Anabolic androgenic steroids, drugs commonly associated with muscle building and enhancing athletic performance, are known to increase the risk for certain health disorders. A new study reveals anabolic steroids may also accelerate brain aging.
Somatic gene mutations in brain cells could account for some of the pathology of schizophrenia.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
